Evidence map›Paper›PMID 38368372›Full record

ArticleContraception and reproductive medicine2024

Comparison of luteal phase stimulation with follicular phase stimulation in poor ovarian response: a single-blinded randomized controlled trial.

Mozhgan Vahabi Dastjerdi, Soheila Ansaripour, Mina Ataei, Roya Gharedaghi, Seyedeh Melika Mostafavi Hoseini, Arash Mohazzab, Simin Zafardoust

Abstract read
In one paragraph

Article in Contraception and reproductive medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: A systematic review and a meta-analysis.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Pooled it
  2. Guideline
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mozhgan Vahabi DastjerdiReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Soheila AnsaripourReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Mina AtaeiReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.ORCID http://orcid.org/0000-0002-0935-7837
Roya GharedaghiDepartment of Obstetrics and Gynecology, Social Determinants of Health, Research Center, School of Medical Sciences, Alborz University of Medical Sciences, Karaj, Iran.ORCID http://orcid.org/0000-0002-3779-1796
Seyedeh Melika Mostafavi HoseiniReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Arash MohazzabDepartment of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Simin ZafardoustReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran. s.zafardoost.imin@gmail.com.ORCID http://orcid.org/0000-0002-9536-395X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the last decade, luteal-phase ovarian stimulation (LPOS) has been suggested as an alternative controlled ovarian stimulation (COS) protocol for in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles mainly in women with a history of poor ovarian response (POR). The present randomized controlled trial study aimed to compare the outcomes of follicular phase ovarian stimulation (FPOS) and LPOS protocols in POR cases undergoing ICSI cycles.

methodsSeventy-eight POR patients who met the Bologna criteria and underwent an ICSI cycle were included. In this study, 39 POR cases were allocated to the FPOS group, and 39 POR cases were allocated to the LPOS group. The primary outcome was the number of metaphase II (MII) oocytes. In addition, the total number of oocytes, number of top-quality day 3 embryo, day 3 embryo development rate, chemical pregnancy and clinical pregnancy rates were defined as secondary outcomes.

resultsThe obtained results demonstrated that the number of MII oocytes significantly increased in the LPOS group compared to the FPOS group (P = 0.007). However, there was no significant difference between the two groups regarding the number of GV and MI oocytes, number of top-quality day 3 embryos and day 3 embryo development rate among both categories of patients. Also, the number of total and MII oocytes was significantly higher in the LPOS group (P = 0.016).

conclusionThese results suggest that LPOS protocol effectively increases the number of mature oocytes in women with a history of POR.

trial registrationIRCT20210405050852N1 (Registered at Iranian registry of clinical trials; available at https://en.irct.ir/trial/55402 ).

Indexed as

Follicular phaseLuteal phaseOvarian stimulationPoor response

Identifiers

PMID38368372
PMCPMC10874545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.